Wearable devices estimate heart rate by sensing either blood-volume changes at the skin surface or the heart’s electrical activity, then converting those signals into beats per minute using signal processing algorithms. Companies and academic groups have refined both approaches; John A. Rogers at Northwestern University has published widely on soft, skin-mounted sensors that improve optical contact, while Mintu P. Turakhia at Stanford University led large-scale evaluations of smartwatch-based arrhythmia detection in collaboration with industry. These technologies enable continuous, noninvasive monitoring but require careful interpretation.
How optical sensors measure pulse
Most wrist-worn trackers use photoplethysmography (PPG), an optical technique. A light-emitting diode shines predominantly green light into the skin and a photodiode measures the amount reflected or transmitted. Each heartbeat subtly changes the volume of blood in microvessels, altering light absorption; the device extracts a periodic waveform that corresponds to pulse timing. Manufacturers apply filtering, peak detection, and adaptive algorithms to remove noise and estimate heart rate. Optical PPG is compact and energy-efficient, making it suitable for consumer wearables, but it is sensitive to motion, ambient light, skin perfusion, and skin pigmentation.
Electrical sensing and clinical applications
Some wearables include electrodes to record single-lead electrocardiography (ECG). An ECG measures the heart’s electrical depolarization events directly, providing higher-fidelity timing for beats and enabling rhythm classification such as atrial fibrillation. The Apple Heart Study coordinated by Mintu P. Turakhia at Stanford University exemplifies a pathway from consumer device data to population-level findings; the study demonstrated that irregular pulse notifications could prompt clinical follow-up. The Food and Drug Administration has granted regulatory clearance to specific smartwatch ECG features for atrial fibrillation detection, reflecting a distinction between consumer wellness functions and medical-grade diagnostics.
Accuracy, causes of error, and consequences
Accuracy varies by sensor type, placement, and context. Optical methods often degrade during vigorous exercise or when wrists move, because motion artifact introduces large, overlapping signals. Researchers including Michael W. Sjoding at the University of Michigan have shown that photoplethysmographic and pulse oximeter measurements can be affected by skin pigmentation, with implications for underdetection in some populations. Low peripheral perfusion, ambient temperature, and improper wear also reduce signal quality. Consequences of misestimation include unnecessary alarms, missed arrhythmias, and potential inequities in detection across demographic groups. Clinicians and regulators therefore recommend that wearable-derived abnormalities be confirmed with clinical-grade ECG or professional evaluation.
Practical relevance and future directions
Wearable heart-rate monitoring empowers self-tracking, population research, and earlier detection of arrhythmias when combined with appropriate clinical pathways. Ongoing engineering advances from academic labs and industry aim to reduce bias and motion sensitivity, while regulatory frameworks and peer-reviewed validation studies guide safe use. Users should view wearable heart-rate outputs as informative but not definitive, and seek medical assessment when devices indicate persistent irregularities or symptoms.